# OnCo record astatine-211-alpha-therapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/astatine-211-alpha-therapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "astatine-211-alpha-therapy" ;
  schema:name "Astatine-211 alpha therapy"@en ;
  schema:description "A rare alpha-emitting halogen that can be attached to antibodies and small molecules like iodine, tested in leukaemia conditioning and brain and ovarian cancer."@en ;
  schema:url <https://onco.cc/technologies/astatine-211-alpha-therapy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Astatine> ;
  schema:citation <https://en.wikipedia.org/wiki/Astatine> ;
  onco:status "phase-1" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:dependsOn <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/medical-cyclotrons-synthesis-modules/> .